At a briefing on Capitol Hill last month sponsored by APA, speakers urged members of Congress to expand the opportunities for healthcare professionals to engage in telemedicine, including telepsychiatry. In particular, they voiced their support for CONNECT for Health Act (S 1016, Creating Opportunities Now for Necessary and Effective Care Technologies), a bipartisan bill first introduced in
A new digital program called reSET has been cleared by the FDA as treatment for substance use disorders. reSET is a 12-week digital therapeutic meant to be used in conjunction with standard outpatient treatment for alcohol, cocaine, marijuana and stimulant SUD’s to improve treatment retention and abstinence. “This is the first piece of software cleared by
A study published in AJP in Advance reports adjunctive bright light therapy may help lower depressive symptoms in adults with bipolar disorder. “Despite advances in drug treatment for mania, the development of effective pharmacotherapy for bipolar depression remains a challenge,” wrote Dorothy Sit, M.D., of the University of Pittsburgh and colleagues. “Given the limited treatment options, research to investigate
A new study by the University Of Missouri School Of Medicine proves that telehealth services help to treat underserved areas. Telepsychiatry, the practice of psychiatry sessions via secure video, is helping to bridge the mental health access gap. Mirna Becevic, Ph.D., an assistant research professor of telemedicine at the MU School of Medicine and
As a Psychiatry resident, experience is crucial and making money to help pay for your education is a close second. Many residents aim to work part time along with their residency in their last 2 years, to help lessen the financial stress as well as gain that wisdom. Obtaining a part time position, though, doesn’t
Telepsychiatry is the use of teleconferencing technology to bring the psychiatrists to patients in underserved areas. The implication of this service results in less travel for many patients and the services have been designed to be understood and used by those of all expertise levels. In a study from Mental Illness performed in Ontario, Canada
In a recent study from The New England Journal of Medicine published on March 31, 2016, the efficacy of Naltrexone (Vivitrol) was tested on those with a history of opioid dependency. This randomized trial compared a 24 week course of extended – release Naltrexone with the usual treatment. The injectable form of Naltrexone (Vivitrol) is
